Loading...
OTCM
BSEM
Market cap65mUSD
Dec 05, Last price  
3.96USD
1D
-7.59%
1Q
-40.97%
Jan 2017
-60.65%
IPO
-100.00%
Name

Biostem Technologies Inc

Chart & Performance

D1W1MN
OTCM:BSEM chart
P/E
2.07
P/S
0.22
EPS
1.91
Div Yield, %
Shrs. gr., 5y
18.59%
Rev. gr., 5y
158.20%
Revenues
302m
+1,708.93%
1,262,3801,363,500806,74015,30931,193151,536592,297328,5281,017,1922,630,3182,521,6394,340,8396,875,20216,685,405301,827,302
Net income
32m
P
-238,277-527,137-3,332,281-441,780-205,597-2,380,450-3,562,811-4,841,407-7,594,973-6,383,601-2,389,232-1,445,383-7,074,861-8,482,98431,884,321
CFO
24m
P
-71,831-273,851-642,567-277,786-97,805-353,576-1,638,741-1,885,050-3,660,417-845,795-581,566-109,439-1,636,943-3,498,96024,476,653

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
IPO date
Jul 11, 2001
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT